Revenue rose 94%, but Webuy Global (WBUY) says recurring losses cast doubt on its ability to keep operating.September 28, 2026
Share Twitter Facebook LinkedIn Email A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024Read More
Revenue rose 94%, but Webuy Global (WBUY) says recurring losses cast doubt on its ability to keep operating.September 28, 2026